Harness Therapeutics
Cambridge
About Harness Therapeutics
Harness Therapeutics is a private biotechnology company focused on the development of a novel class of therapeutic RNAs that can upregulate protein expression with an unprecedented level of control and specificity: the SINEUPs®. The company's pioneering technology is expected to offer an entirely unique mechanism of action for currently hard-to-treat diseases by massively extending the druggable proteome and allowing it to address diseases that have been beyond the reach of small molecules, conventional biologics, or gene therapies. We have a particular focus on CNS and opthalmologic disorders but our platform has applications in multiple therapy areas
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $23.8M
- Last round: Series Unknown (Jan 2025)
- Website: harnesstx.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/harness-therapeutics-58591 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.